Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
Experimental RNAi02:15

Experimental RNAi

6.7K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The <i>in vivo</i> CAR-T paradigm shift-Reflections from Boston and the rise of programmable immunity.

Molecular therapy. Nucleic acids·2026
Same author

Scaling the RNA Summit: Reflections on the 2026 OPT congress.

Molecular therapy. Nucleic acids·2026
Same author

The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena.

Molecular therapy. Nucleic acids·2026
Same author

Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity.

International journal of biological macromolecules·2026
Same author

Advancing the science of nucleic acids together.

Molecular therapy. Nucleic acids·2026
Same author

<i>FMR1</i> RNA interaction with DNMT1 blocks DNA methylation at the <i>FMR1 locus</i>.

NAR molecular medicine·2026

Related Experiment Video

Updated: Nov 7, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.4K

Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.

Silvia Catuogno1, Carla Lucia Esposito2, Paloma H Giangrande3

  • 1Istituto per l'Endocrinologia ed Oncologia Sperimentale, CNR, Naples, Italy. s.catuogno@ieos.cnr.it.

Methods in Molecular Biology (Clifton, N.J.)
|April 30, 2021
PubMed
Summary

Aptamer-siRNA chimeras offer a novel strategy for targeted delivery of small interfering RNA (siRNA) therapeutics. This method enables efficient and selective delivery of siRNA to diseased cells, overcoming a key hurdle in clinical translation.

Keywords:
AptamersNon-covalent constructsTargeted deliveryTargeted therapysiRNAs

More Related Videos

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.2K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

19.8K

Related Experiment Videos

Last Updated: Nov 7, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.4K
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

11.2K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

19.8K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Delivery Systems

Background:

  • Small interfering RNA (siRNA) holds therapeutic potential but lacks targeted delivery methods.
  • Selective organ and tissue targeting remains a critical challenge for clinical siRNA applications.

Purpose of the Study:

  • To describe a novel method for targeted siRNA delivery using aptamers.
  • To provide a protocol for generating aptamer-siRNA chimeras for enhanced therapeutic delivery.

Main Methods:

  • Design and generation of aptamer-siRNA chimeras via annealing complementary sequences.
  • Utilizing nucleic acid aptamers that target cell surface epitopes for specific targeting.
  • Employing a modular, non-covalent approach for construct generation.

Main Results:

  • Demonstrated a fast and simple protocol for creating aptamer-siRNA chimeras.
  • Achieved efficient delivery of the siRNA moiety into target cells via aptamer recognition.
  • Enabled modular, non-covalent generation of targeted delivery constructs.

Conclusions:

  • Aptamer-siRNA chimeras represent a promising strategy for targeted therapeutic delivery.
  • This approach facilitates selective delivery of siRNA to diseased cells, advancing clinical translation.
  • The described protocol offers a practical method for generating these targeted constructs.